Entera Bio (ENTX) EPS (Diluted) (2019 - 2026)

Entera Bio (ENTX) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 0.00
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 6.75
7 Belite Bio 62.72 Bn 62.72 Bn - 0.00
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 7.33
9 Revolution Medicines 37.35 Bn 37.35 Bn - -2.29
10 Entera Bio 186.78 Mn 182.64 Mn - -0.08

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.08
Dec 31, 2025 -0.07
Sep 30, 2025 -0.07
Jun 30, 2025 -0.06
Mar 31, 2025 -0.06
Dec 31, 2024 -0.06
Sep 30, 2024 -0.08
Jun 30, 2024 -0.07
Mar 31, 2024 -0.06
Dec 31, 2023 -0.07
Sep 30, 2023 -0.08
Jun 30, 2023 -0.08
Mar 31, 2023 -0.08
Dec 31, 2022 -0.11
Sep 30, 2022 -0.11
Jun 30, 2022 -0.11
Mar 31, 2022 -0.13
Dec 31, 2021 -0.16
Sep 30, 2021 -0.11
Jun 30, 2021 -0.10